New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
10:01 EDTNYX, MDRX, TCRD, ICE, BOCH, MLNX, HLF, RIMM, GG, FOLD, KBH, DFS, DAR, NKE, ELOQOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Amicus Theraputics (FOLD) downgraded to Underperform from Neutral at Wedbush... Bank of Commerce Holdings (BOCH) downgraded to Market Perform at Raymond James... Eloqua (ELOQ) downgraded to Neutral from Overweight at JPMorgan... Goldcorp (GG) downgraded to Neutral from Outperform at Credit Suisse... IntercontinentalExchange (ICE) downgraded to Market Perform at Bernstein... Nike (NKE) downgraded to Neutral from Buy at Janney Capital... Research in Motion (RIMM) downgraded to Sell from Underperform at CLSA... THL Credit (TCRD) downgraded to Hold from Buy at Deutsche Bank... Darling (DAR) downgraded to Equal Weight from Overweight at Stephens... Herbalife (HLF) downgraded to Hold from Buy at Argus... Allscripts (MDRX) downgraded to Hold from Buy at Argus... Discover (DFS) downgraded to Market Perform from Outperform at FBR Capital... Mellanox (MLNX) downgraded to Hold from Buy at Maxim... NYSE Euronext (NYX) downgraded to Market Perform from Outperform at Keefe Bruyette... KB Home (KBH) downgraded to Sell from Hold at Williams Capital.
News For FOLD;BOCH;ELOQ;GG;ICE;NKE;RIMM;TCRD;DAR;HLF;MDRX;DFS;MLNX;NYX;KBH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
March 19, 2015
06:07 EDTFOLDAmicus reports positive results in meetings with EMA and FDA
Amicus has met with regulatory authorities in Europe and the U.S. to discuss the approval pathways for the oral small molecule pharmacological chaperone migalastat HCl as a precision medicine monotherapy for Fabry patients who have amenable genetic mutations. The company held a meeting with the assigned European Rapporteurs to discuss the upcoming marketing authorization application for migalastat monotherapy. The Rapporteurs agreed that Amicus may submit its MAA for migalastat monotherapy under the Full Approval pathway in the EU and indicated support for Amicus to request Accelerated Assessment. Amicus is accelerating the timing of the MAA submission for full approval for migalastat monotherapy from the middle of 2015 to Q2. Amicus held a Type C meeting with the FDA and plans to submit an NDA for Accelerated Approval, for which the FDA is open to considering several potential surrogate endpoints evaluated in the clinical studies of migalastat. Amicus plans to schedule a pre-NDA meeting and to submit an NDA under Subpart H in 2H15
March 18, 2015
13:49 EDTHLFHerbalife says 'confident in strong fundamentals of business model'
Subscribe for More Information
12:44 EDTKBHKB Home March volatility elevated into Q1 and outlook
KB Home March call option implied volatility is at 96, April is at 43, July is at 37; compared to its 26-week average of 35 according to Track Data, suggesting large near term price movement into the expected release of Q1 results on March 20.
09:23 EDTHLFOn The Fly: Pre-market Movers
Subscribe for More Information
08:02 EDTHLFHerbalife wins dismissal of class action 'pyramid scheme' lawsuit
On March 16, a judge in the U.S. District Court for the Central District of California granted Herbalife its motion to dismiss a class action complaint brought on behalf of shareholders who allege that the company and its executives violated federal securities laws by misrepresenting the "nature, scope and legality" of the company's business and operations. According to the plaintiffs, Herbalife and its executives, including CEO Michael Johnson, misrepresented Herbalife as a legitimate multi-level marketing company when it "is actually an illegal pyramid scheme." The court concluded that the suit's plaintiffs have not adequately pled loss causation, meaning that the court need not consider Herbalife’s alternative arguments, according to a court filing. Shares of Herbalife are up 3% in pre-market trading after the court dismissal was widely reported by Bloomberg last night.
07:59 EDTNKENike March volatility elevated into Q3 and outlook
Nike March call option implied volatility is at 69, April is at 28, May is at 23, July is at 22; compared to its 26-week average of 23 according to Track Data, suggesting large near term price movement into the expected release of Q3 results on March 19.
07:13 EDTHLFHerbalife complaint letter signer subpoenaed, Hartford Courant reports
Subscribe for More Information
March 17, 2015
19:42 EDTHLFOn The Fly: After Hours Movers
Subscribe for More Information
18:27 EDTHLFHerbalife up over 5% following favorable court ruling in 'pyramid scheme' suit
Subscribe for More Information
18:07 EDTHLFHerbalife wins dismissal of 'pyramid scheme' lawsuit, Bloomberg says
10:26 EDTFOLD, HLFOptions with increasing implied volatility
Subscribe for More Information
March 16, 2015
11:48 EDTNKEadidas won't renew contract with NBA after 2016-17 season, ESPN reports
Subscribe for More Information
11:47 EDTICECFTC orders ICE Futures U.S. to pay $3M civil monetary penalty
Subscribe for More Information
10:49 EDTNKENike March volatility increases into Q3 and outlook
Subscribe for More Information
10:02 EDTGGOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AmerisourceBergen (ABC) upgraded to Buy from Neutral at UBS... Avago (AVGO) upgraded to Buy from Neutral at DA Davidson... Francesca's (FRAN) upgraded to Buy at Janney Capital... Goldcorp (GG) upgraded to Overweight from Neutral at HSBC... Jabil Circuit (JBL) upgraded to Buy from Hold at Cross Research... JetBlue (JBLU) upgraded to Outperform at Raymond James... King Digital (KING) upgraded to Overweight from Neutral at JPMorgan... L.B. Foster (FSTR) upgraded to Outperform from Neutral at Macquarie... NextEra Energy (NEE) upgraded to Buy from Hold at Deutsche Bank... Petrobras Argentina (PZE) upgraded to Buy from Neutral at BofA/Merrill... Qorvo (QRVO) upgraded to Buy from Neutral at DA Davidson... Randgold (GOLD) upgraded to Overweight from Neutral at HSBC... Royal Gold (RGLD) upgraded to Overweight from Neutral at HSBC... Seagate (STX) upgraded at Needham... Standex (SXI) upgraded to Buy from Hold at BB&T... Union Pacific (UNP) upgraded to Outperform from Neutral at Macquarie... West Corp. (WSTC) upgraded to Outperform from Neutral at RW Baird... Xilinx (XLNX) upgraded to Buy from Hold at Drexel Hamilton... YPF (YPF) upgraded to Buy from Neutral at BofA/Merrill.
08:22 EDTDFSDiscover reports 2.7% net principal charge-off rate in February
Subscribe for More Information
07:24 EDTNKENike has solid global demand ahead but FX a headwind, says Credit Suisse
Subscribe for More Information
06:54 EDTGGGoldcorp upgraded to Overweight from Neutral at HSBC
Subscribe for More Information
06:00 EDTICENYSE owner warns of cyber risk to frequency trading, Financial Times says
IntercontinentalExchange CEO Jeff Sprecher warned that efforts to fend off cyber hackers could reverse the momentumtowards faster markets, reports the Financial Times. Sprecher adds that the growing risk of cyber attacks would force traders to pass new electronic sentries as they connect to his exchanges. Reference Link
05:50 EDTHLFStocks with implied volatility movement; FIG HLF
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use